34 /100
MEDIUM RISK
Score updated May 30, 2026

PRME — Prime Medicine, Inc. Dilution Risk Tracker

Track PRME dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PRME — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
12%
📉 Score Deterioration 25%
• Score increased 14 points recently (worsening)
🔔 Track PRME — Get forecast alerts →

💹 Market Data

Market Cap$641.19M
Shares Outstanding180.62M
Float108.73M
Cash$135.50M
Debt$114.51M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 9.5% shares (2025Q4 vs prior)
187 institutional holders · 104.55M shares
#1 Alphabet Inc. 16.56M shares
#2 BlackRock, Inc. 8.27M shares
#3 T. Rowe Price Investment Management, Inc. 7.09M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest30.53M
Days to Cover11.7
% of Float28.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2022
EFFECT EFFECT Mar 04, 2026
4 INSIDER TRANSACTION Feb 27, 2026
4 INSIDER TRANSACTION Feb 24, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PRME Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PRME — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PRME
📊 PRME FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PRME Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.